MM MBRACE THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 08 Sept 2026)
What this means for you
Not registered yet, but its 26 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98378002
- Mark type
- Design + words
- Filed
- 26 Jan 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Rebeccah Gan
Goods and services
- Class 005 — Pharmaceuticals: Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors
- Class 044 — Medical, beauty and agricultural services: Antibody testing for medical diagnostic or treatment purposes
Owner
- MBrace Therapeutics, Inc., San Diego, CA, US
- MBrace Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 09 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2026 — SOU EXTENSION 4 GRANTED
- 08 Sept 2026 — SOU EXTENSION 4 FILED
- 08 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 3 GRANTED
- 02 Apr 2026 — SOU EXTENSION 3 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2025 — SOU EXTENSION 1 GRANTED
- 09 May 2025 — SOU EXTENSION 1 FILED